Cancer Research  AM No Date
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, W.
Right arrow Articles by Ellis, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, W.
Right arrow Articles by Ellis, L. M.
[Cancer Research 63, 3632-3636, July 1, 2003]
© 2003 American Association for Cancer Research


Experimental Therapeutics

Cyclooxygenase-2 Is Up-Regulated by Interleukin-1ß in Human Colorectal Cancer Cells via Multiple Signaling Pathways1

Wenbiao Liu, Niels Reinmuth, Oliver Stoeltzing, Alexander A. Parikh, Carmen Tellez, Simon Williams, Young D. Jung, Fan Fan, Akihiko Takeda, Morihisa Akagi, Menashe Bar-Eli, Gary E. Gallick and Lee M. Ellis2

Departments of Cancer Biology [W. L., N. R., O. S., C. T., S. W., Y. D. J., F. F., A. T., M. A., M. B-E., G. E. G., L. M. E.] and Surgical Oncology [A. A. P., L. M. E.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009

Overexpression of cyclooxygenase-2 (COX-2) has been observed in human colorectal cancer. COX-2 expression in human tumors can be induced by growth factors, cytokines, oncogenes, and other factors. The mechanisms regulating COX-2 expression in human colon cancer have not been completely elucidated. We hypothesized that the proinflammatory cytokine interleukin-1ß (IL-1ß) mediates COX-2 expression in HT-29 human colon cancer cells. Treatment of HT-29 cells with IL-1ß induced expression of COX-2 mRNA and protein in a time- and dose-dependent manner. Inhibitors of the extracellular signal-regulated kinase 1/2, c-Jun NH2-terminal kinase, P38 mitogen-activated protein kinase, and nuclear factor-{kappa}B (NF-{kappa}B) signaling pathways blocked the ability of IL-1ß to induce COX-2 mRNA. In contrast, Wortmannin, a phosphoinositide 3-kinase inhibitor upstream of protein kinase B/Akt, led to a slight increase in COX-2 mRNA expression after IL-1ß treatment. Electrophoretic mobility shift assay on nuclear extracts demonstrated that IL-1ß induced NF-{kappa}B DNA binding activity in HT-29 cells, and the activated NF-{kappa}B complex was eliminated after treatment with an inhibitor of NF-{kappa}B. Supershift assay indicated that the two NF-{kappa}B subunits, p65 and p50, were involved in activation of NF-{kappa}B complex by IL-1ß stimulation. The stability of COX-2 mRNA was not altered by IL-1ß treatment. These data demonstrate that IL-1ß induces COX-2 expression in HT-29 cells through multiple signaling pathways and NF-{kappa}B.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
B.-C. Jang, S.-H. Sung, J.-G. Park, J.-W. Park, J. H. Bae, D. H. Shin, G.-Y. Park, S.-B. Han, and S.-I. Suh
Glucosamine Hydrochloride Specifically Inhibits COX-2 by Preventing COX-2 N-Glycosylation and by Increasing COX-2 Protein Turnover in a Proteasome-dependent Manner
J. Biol. Chem., September 21, 2007; 282(38): 27622 - 27632.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Wohlschlaeger, K. J. Schmitz, J. Palatty, A. Takeda, N. Takeda, C. Vahlhaus, B. Levkau, J. Stypmann, C. Schmid, K. W. Schmid, et al.
Roles of cyclooxygenase-2 and phosphorylated Akt ( T hr308) in cardiac hypertrophy regression mediated by left-ventricular unloading
J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 37 - 43.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. R. Yan, R. R. Joseph, J. Wang, and A. W. Stadnyk
Differential Pattern of Inflammatory Molecule Regulation in Intestinal Epithelial Cells Stimulated with IL-1
J. Immunol., October 15, 2006; 177(8): 5604 - 5611.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Tammali, K. V. Ramana, S. S. Singhal, S. Awasthi, and S. K. Srivastava
Aldose Reductase Regulates Growth Factor-Induced Cyclooxygenase-2 Expression and Prostaglandin E2 Production in Human Colon Cancer Cells
Cancer Res., October 1, 2006; 66(19): 9705 - 9713.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H.-W. Koon, D. Zhao, Y. Zhan, S. H. Rhee, M. P. Moyer, and C. Pothoulakis
Substance P Stimulates Cyclooxygenase-2 and Prostaglandin E2 Expression through JAK-STAT Activation in Human Colonic Epithelial Cells.
J. Immunol., April 15, 2006; 176(8): 5050 - 5059.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Thiel, M. Heinonen, J. Rintahaka, T. Hallikainen, A. Hemmes, D. A. Dixon, C. Haglund, and A. Ristimaki
Expression of Cyclooxygenase-2 Is Regulated by Glycogen Synthase Kinase-3beta in Gastric Cancer Cells
J. Biol. Chem., February 24, 2006; 281(8): 4564 - 4569.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Ha, J.-H. Lee, H.-N. Kim, H.-M. Kim, H. B. Kwak, S. Lee, H.-H. Kim, and Z. H. Lee
{alpha}-Lipoic Acid Inhibits Inflammatory Bone Resorption by Suppressing Prostaglandin E2 Synthesis
J. Immunol., January 1, 2006; 176(1): 111 - 117.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
W. Wu, R. A. Silbajoris, Y. E. Whang, L. M. Graves, P. A. Bromberg, and J. M. Samet
p38 and EGF receptor kinase-mediated activation of the phosphatidylinositol 3-kinase/Akt pathway is required for Zn2+-induced cyclooxygenase-2 expression
Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L883 - L889.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M.-T. Lin, C.-Y. Zuon, C.-C. Chang, S.-T. Chen, C.-P. Chen, B.-R. Lin, M.-Y. Wang, Y.-M. Jeng, K.-J. Chang, P.-H. Lee, et al.
Cyr61 Induces Gastric Cancer Cell Motility/Invasion via Activation of the Integrin/Nuclear Factor-{kappa}B/Cyclooxygenase-2 Signaling Pathway
Clin. Cancer Res., August 15, 2005; 11(16): 5809 - 5820.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Wojciechowski, H. Li, S. Marshall, C. Dell'Agnola, and I. Espinoza-Delgado
Enhanced Expression of CD20 in Human Tumor B Cells Is Controlled through ERK-Dependent Mechanisms
J. Immunol., June 15, 2005; 174(12): 7859 - 7868.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
T. Hall-Pogar, H. Zhang, B. Tian, and C. S. Lutz
Alternative polyadenylation of cyclooxygenase-2
Nucleic Acids Res., May 4, 2005; 33(8): 2565 - 2579.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. L. Gauthier, C. R. Pickering, C. J. Miller, C. A. Fordyce, K. L. Chew, H. K. Berman, and T. D. Tlsty
p38 Regulates Cyclooxygenase-2 in Human Mammary Epithelial Cells and Is Activated in Premalignant Tissue
Cancer Res., March 1, 2005; 65(5): 1792 - 1799.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-H. Hung, I.-J. Su, H.-Y. Lei, H.-C. Wang, W.-C. Lin, W.-T. Chang, W. Huang, W.-C. Chang, Y.-S. Chang, C.-C. Chen, et al.
Endoplasmic Reticulum Stress Stimulates the Expression of Cyclooxygenase-2 through Activation of NF-{kappa}B and pp38 Mitogen-activated Protein Kinase
J. Biol. Chem., November 5, 2004; 279(45): 46384 - 46392.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
N. Ishimura, S. F. Bronk, and G. J. Gores
Inducible nitric oxide synthase upregulates cyclooxygenase-2 in mouse cholangiocytes promoting cell growth
Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G88 - G95.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. H. Schonthal, C. R. Herzog, M. V. Swamy, and C. V. Rao
Correspondence re: M. V. Swamy et al., Inhibition of COX-2 in Colon Cancer Cell Lines by Celecoxib Increases the Nuclear Localization of Active p53. Cancer Res 2003;63:5239-42.
Cancer Res., April 15, 2004; 64(8): 2937 - 2938.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.